类风湿关节炎患者接受治疗时，是否应检测抗TNF-α药物水平和/或抗药物抗体？ - Suppr

Suppr

超能文献

Should anti-TNF-α drug levels and/or anti-drug antibodies be assayed in patients treated for rheumatoid arthritis?

作者信息

Mulleman Denis, Ducourau Emilie, Paintaud Gilles, Ternant David, Watier Hervé, Goupille Philippe

出版信息

Joint Bone Spine. 2012 Mar;79(2):109-12. doi: 10.1016/j.jbspin.2011.11.004. Epub 2012 Feb 20.

DOI:10.1016/j.jbspin.2011.11.004

PMID:22356754

Abstract

摘要

相似文献

Should anti-TNF-α drug levels and/or anti-drug antibodies be assayed in patients treated for rheumatoid arthritis?

Joint Bone Spine. 2012 Mar;79(2):109-12. doi: 10.1016/j.jbspin.2011.11.004. Epub 2012 Feb 20.

Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis.

Joint Bone Spine. 2016 Oct;83(5):595-7. doi: 10.1016/j.jbspin.2015.07.015. Epub 2016 Apr 8.

High levels of human anti-human antibodies to adalimumab in a patient not responding to adalimumab treatment.

Ann Rheum Dis. 2006 Sep;65(9):1249-50. doi: 10.1136/ard.2005.049858.

Is there a need for immunopharmacologic guidance of anti-tumor necrosis factor therapies?

Arthritis Rheum. 2011 Apr;63(4):867-70. doi: 10.1002/art.30207.

Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner.

Ann Rheum Dis. 2012 Nov;71(11):1914-5. doi: 10.1136/annrheumdis-2012-201544. Epub 2012 May 14.

The frequency of anti-infliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure.

Rheumatology (Oxford). 2013 Jul;52(7):1245-53. doi: 10.1093/rheumatology/ket017. Epub 2013 Mar 4.

Golimumab trough levels, antidrug antibodies and clinical response in patients with rheumatoid arthritis treated in daily clinical practice.

Ann Rheum Dis. 2014 Dec;73(12):2217-9. doi: 10.1136/annrheumdis-2014-205983. Epub 2014 Sep 26.

Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.

Arthritis Rheum. 2006 Dec;54(12):3782-9. doi: 10.1002/art.22214.

TNF inhibitors: a new age in rheumatoid arthritis treatment.

Am J Nurs. 2004 Feb;104(2):60-8; quiz 68-9. doi: 10.1097/00000446-200402000-00023.

Towards an individualised target concentration of adalimumab in rheumatoid arthritis.

Ann Rheum Dis. 2014 Jul;73(7):1428-9. doi: 10.1136/annrheumdis-2013-204971. Epub 2014 Feb 18.

引用本文的文献

Exposure-Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis.

Clin Transl Sci. 2020 Jul;13(4):743-751. doi: 10.1111/cts.12760. Epub 2020 Apr 1.

Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration.

Clin Pharmacokinet. 2018 Sep;57(9):1173-1184. doi: 10.1007/s40262-017-0621-6.

Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases.

Clin Pharmacol. 2017 Oct 3;9:101-111. doi: 10.2147/CPAA.S138414. eCollection 2017.

Effect of Infliximab Dose Increase in Rheumatoid Arthritis at Different Trough Concentrations: A Cohort Study in Clinical Practice Conditions.

Front Med (Lausanne). 2015 Oct 8;2:71. doi: 10.3389/fmed.2015.00071. eCollection 2015.

Therapeutic vaccination with TNF-Kinoid in TNF antagonist-resistant rheumatoid arthritis: a phase II randomized, controlled clinical trial.

PLoS One. 2014 Dec 17;9(12):e113465. doi: 10.1371/journal.pone.0113465. eCollection 2014.

Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis.

Br J Clin Pharmacol. 2014 Jul;78(1):118-28. doi: 10.1111/bcp.12313.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验